(Q36570328)

15 August 2017

0 references

Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska (English)

1 reference

15 August 2017

Mark V Siracuse

1

1 reference

15 August 2017

Phillip J Vuchetich

series ordinal

2

1 reference

15 August 2017

1 February 2008

1 reference

15 August 2017

Health Services Research

1 reference

15 August 2017

43

1 reference

15 August 2017

1 Pt 2

1 reference

15 August 2017

435-450

1 reference

describes a project that uses

15 August 2017

SQL

1 reference

26 June 2022

https://europepmc.org/article/PMC/PMC2323130

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2323130

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2323130

Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2323130

Promotion of prescription drugs to consumers.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2323130

Gastrointestinal bleeding rates among managed care patients newly started on cox-2 inhibitors or nonselective NSAIDs

28 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1475-6773.2007.00766.X

National health spending in 2004: recent slowdown led by prescription drug spending

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2323130

Medical and pharmacy expenditures after implementation of a cyclooxygenase-2 inhibitor prior authorization program

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2323130

Effects of a prior-authorization policy for celecoxib on medical service and prescription drug use in a managed care Medicaid population

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2323130

Pharmacoeconomic Modeling of Prior-Authorization Intervention for COX-2 Specific Inhibitors in a 3-Tier Copay Plan

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2323130

Impact of NSAIDs prior authorization policy on patients' QoL.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2323130

Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2323130

Controlling spending for prescription drugs

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2323130

Relative value of the NSAIDs, including COX-2 inhibitors and meloxicam

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18199195

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Prior-authorization programs for controlling drug spending

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18199195

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/J.1475-6773.2007.00766.X

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

18199195

1 reference